| Dekalb Health Medical Group-garrett | |
|
128 N Randolph St Garrett IN 46738-1138 | |
| (260) 357-6557 | |
| (260) 357-0373 |
| Full Name | Dekalb Health Medical Group-garrett |
|---|---|
| Speciality | Family Medicine |
| Location | 128 N Randolph St, Garrett, Indiana |
| Authorized Official Name and Position | Penny Lynn Griffin (BILLING COLLECTION MANAGER) |
| Authorized Official Contact | 2609202794 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Dekalb Health Medical Group-garrett Po Box 623 Auburn IN 46706-0623 Ph: (260) 357-6557 | Dekalb Health Medical Group-garrett 128 N Randolph St Garrett IN 46738-1138 Ph: (260) 357-6557 |
| NPI Number | 1508937376 |
|---|---|
| Provider Enumeration Date | 11/13/2006 |
| Last Update Date | 01/12/2012 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508937376 | NPI | - | NPPES |
| 100104110E | Medicaid | IN | |
| CC4531 | Other | IN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
News Archive
A team of researchers led by Patrick E. H. Jackson at the Myles H. Thaler Center for HIV and Human Retrovirus Research, University of Virginia, Charlottesville, Virginia, USA, has published a review on the subject of the HIV-1 Rev Regulatory complex (dubbed the HIV-1 Rev Regulatory Axis) in the journal, Current HIV Research.
An enzyme that naturally occurs in the brain helps destroy the mutated protein that is the most common cause of inherited Parkinson's disease, researchers at UT Southwestern Medical Center have found.
CleveMed recently received ISO 13485 certification issued by BSI Management Systems America Inc., one of the foremost auditing bodies in the world. CleveMed has also received the CE Mark and CMDCAS allowing its products to be distributed to the large European and the Canadian markets which will strengthen its worldwide market presence.
For the first time, a combination of aspirin and the anti-platelet drug dipyridamole has been shown to significantly reduce blockages and extend the useful life of new artery-vein access grafts used for hemodialysis, according to a study by the Dialysis Access Consortium (DAC).
QLT Inc., a company dedicated to the development and commercialization of innovative therapies for the eye, announced today that the company has been added to the Russell Global Index. The 2010 reconstitution of the Russell Indexes, a comprehensive set of U.S. and global equity indexes created by Russell Investments, took place after the market close on June 25, 2010.
› Verified 9 days ago